• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无论 CD34 表达如何,谱系定向细胞分数都会重建并重新建立 NOD/SCID/IL-2Rgammac-/- 小鼠中的费城染色体阳性白血病。

Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rgammac-/- mice.

机构信息

Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Cancer Sci. 2010 Mar;101(3):631-8. doi: 10.1111/j.1349-7006.2009.01440.x. Epub 2009 Nov 16.

DOI:10.1111/j.1349-7006.2009.01440.x
PMID:20028384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11159776/
Abstract

Stem cells of acute myeloid leukemia (AML) have been identified as immunodeficient mouse-repopulating cells with a Lin(-)CD34(+)38(-) phenotype similar to normal hematopoietic stem cells. To identify the leukemia-propagating stem cell fraction of Philadelphia chromosome-positive (Ph(+)) leukemia, we serially transplanted human leukemia cells from patients with chronic myeloid leukemia blast crisis (n = 3) or Ph(+) acute lymphoblastic leukemia (n = 3) into NOD/SCID/IL-2Rgammac(-/-) mice. Engrafted cells were almost identical to the original leukemia cells as to phenotypes, IGH rearrangements, and karyotypes. CD34(+)CD38(-)CD19(+), CD34(+)38(+)CD19(+), and CD34(-)CD38(+)CD19(+) fractions could self-renew and transfer the leukemia, whereas the CD34(-)CD38(+)CD19(+) fraction did not stably propagate in NOD/SCID mice. These findings suggest that leukemia-repopulating cells in transformed Ph(+) leukemia are included in a lineage-committed but multilayered fraction, and that CD34(+) leukemia cells potentially emerge from CD34(-) populations.

摘要

急性髓系白血病 (AML) 的干细胞被鉴定为免疫缺陷的小鼠再群体细胞,其 Lin(-)CD34(+)38(-)表型类似于正常造血干细胞。为了鉴定费城染色体阳性 (Ph(+)) 白血病的白血病增殖干细胞部分,我们将来自慢性髓系白血病急变期患者的人白血病细胞(n=3)或 Ph(+)急性淋巴细胞白血病患者的人白血病细胞(n=3)连续移植到 NOD/SCID/IL-2Rgammac(-/-) 小鼠中。植入的细胞在表型、IGH 重排和核型方面与原始白血病细胞几乎完全相同。CD34(+)CD38(-)CD19(+)、CD34(+)38(+)CD19(+)和 CD34(-)CD38(+)CD19(+) 部分可以自我更新并转移白血病,而 CD34(-)CD38(+)CD19(+) 部分在 NOD/SCID 小鼠中不能稳定地增殖。这些发现表明,转化的 Ph(+)白血病中的白血病再群体细胞包含在一个谱系定向但多层次的部分中,并且 CD34(+)白血病细胞可能从 CD34(-)群体中出现。

相似文献

1
Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rgammac-/- mice.无论 CD34 表达如何,谱系定向细胞分数都会重建并重新建立 NOD/SCID/IL-2Rgammac-/- 小鼠中的费城染色体阳性白血病。
Cancer Sci. 2010 Mar;101(3):631-8. doi: 10.1111/j.1349-7006.2009.01440.x. Epub 2009 Nov 16.
2
Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells.人脐带血细胞在巨噬细胞缺失的SCID小鼠中的移植:辅助细胞参与未成熟CD34+CD38-细胞扩增的证据
Blood. 1998 Mar 15;91(6):1966-76.
3
A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia.原始造血细胞是人类费城染色体阳性急性淋巴细胞白血病白血病转化的靶细胞。
Blood. 2000 Feb 1;95(3):1007-13.
4
CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.CD34+CD38+CD19+以及CD34+CD38-CD19+细胞是人类B前体急性淋巴细胞白血病中具有自我更新能力的白血病起始细胞。
Leukemia. 2008 Jun;22(6):1207-13. doi: 10.1038/leu.2008.83. Epub 2008 Apr 17.
5
Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function.在逆转录病毒转导过程中,人脐带血CD34(+)CD38(-)细胞在体外培养中扩增,但严重联合免疫缺陷(SCID)重建细胞(SRC)频率没有相应增加:SRC表型与功能的分离。
Blood. 2000 Jan 1;95(1):102-10.
6
Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.来自个别慢性髓性白血病患者的恶性和正常造血祖细胞在免疫缺陷小鼠中的多谱系生长。
Leukemia. 1999 Apr;13(4):618-28. doi: 10.1038/sj.leu.2401366.
7
Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.体外扩增后人外周血CD34(+)细胞中干细胞表型与NOD/SCID重建造血活性之间的解离
Exp Hematol. 2001 Dec;29(12):1465-73. doi: 10.1016/s0301-472x(01)00750-0.
8
Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice.人CD34(+)CD38(-/低)CXCR4(+)干细胞和祖细胞快速高效归巢至NOD/SCID和NOD/SCID/B2m(null)小鼠的骨髓和脾脏。
Blood. 2001 May 15;97(10):3283-91. doi: 10.1182/blood.v97.10.3283.
9
Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells.人类B-1和B-2 B细胞由Lin-CD34+CD38lo干细胞发育而来。
J Immunol. 2016 Nov 15;197(10):3950-3958. doi: 10.4049/jimmunol.1600630. Epub 2016 Oct 7.
10
Phenotyping and Target Expression Profiling of CD34/CD38 and CD34/CD38 Stem- and Progenitor cells in Acute Lymphoblastic Leukemia.在急性淋巴细胞白血病中,CD34/CD38 和 CD34/CD38 干细胞和祖细胞的表型和靶表达分析。
Neoplasia. 2018 Jun;20(6):632-642. doi: 10.1016/j.neo.2018.04.004. Epub 2018 May 15.

引用本文的文献

1
Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells.成人造血干/祖细胞及白血病干细胞的分离、培养与扩增
Cancers (Basel). 2022 Mar 28;14(7):1723. doi: 10.3390/cancers14071723.
2
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML.白血病干细胞:CML 和 AML 中的相似性、差异性和临床前景。
Nat Rev Cancer. 2020 Mar;20(3):158-173. doi: 10.1038/s41568-019-0230-9. Epub 2020 Jan 6.
3
The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib.光敏剂维替泊芬对Ph阳性急性淋巴细胞白血病具有光非依赖性抗白血病活性,并与达沙替尼协同作用。
Oncotarget. 2016 Aug 30;7(35):56241-56252. doi: 10.18632/oncotarget.11025.
4
Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells.通过使用患者来源的异种移植细胞进行筛选发现一种靶向淋巴瘤细胞微环境支持的药物。
Sci Rep. 2015 Aug 17;5:13054. doi: 10.1038/srep13054.
5
Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia.急性淋巴细胞白血病中的干细胞层级结构与克隆进化
Stem Cells Int. 2015;2015:137164. doi: 10.1155/2015/137164. Epub 2015 Jul 6.
6
A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases.新型 STAT 抑制剂 OPB-31121 对依赖 STAT 的癌激酶的白血病具有显著的抗肿瘤作用。
Blood Cancer J. 2013 Nov 29;3(11):e166. doi: 10.1038/bcj.2013.63.
7
The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells.mTOR 抑制剂依维莫司(RAD001)克服静止期 Ph 阳性急性淋巴细胞白血病细胞对伊马替尼的耐药性。
Blood Cancer J. 2011 May;1(5):e17. doi: 10.1038/bcj.2011.16. Epub 2011 May 13.

本文引用的文献

1
Malignant stem cells in childhood ALL: the debate continues!儿童急性淋巴细胞白血病中的恶性干细胞:争论仍在继续!
Blood. 2009 Apr 30;113(18):4476-7; author reply 4477. doi: 10.1182/blood-2009-02-203109.
2
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.糖原合酶激酶3β剪接异常促成白血病干细胞的产生。
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3925-9. doi: 10.1073/pnas.0900189106. Epub 2009 Feb 23.
3
Expression of CD133 on leukemia-initiating cells in childhood ALL.儿童急性淋巴细胞白血病中白血病起始细胞上CD133的表达。
Blood. 2009 Apr 2;113(14):3287-96. doi: 10.1182/blood-2008-04-154187. Epub 2009 Jan 15.
4
Leukemia stem cells and human acute lymphoblastic leukemia.白血病干细胞与人类急性淋巴细胞白血病
Semin Hematol. 2009 Jan;46(1):33-8. doi: 10.1053/j.seminhematol.2008.09.010.
5
Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy.伊马替尼治疗后慢性髓性白血病造血干细胞中BCR-ABL转录本的保留但显著减少。
Int J Hematol. 2008 Dec;88(5):471-475. doi: 10.1007/s12185-008-0221-1. Epub 2008 Nov 29.
6
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.在儿童急性淋巴细胞白血病中,处于免疫表型成熟不同阶段的原始细胞具有干细胞特性。
Cancer Cell. 2008 Jul 8;14(1):47-58. doi: 10.1016/j.ccr.2008.05.015.
7
CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.CD34+CD38+CD19+以及CD34+CD38-CD19+细胞是人类B前体急性淋巴细胞白血病中具有自我更新能力的白血病起始细胞。
Leukemia. 2008 Jun;22(6):1207-13. doi: 10.1038/leu.2008.83. Epub 2008 Apr 17.
8
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.BCR-ABL1 淋巴细胞白血病的特征是 Ikaros 缺失。
Nature. 2008 May 1;453(7191):110-4. doi: 10.1038/nature06866. Epub 2008 Apr 13.
9
Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.TEL-AML1相关儿童白血病中的起始细胞和癌症增殖细胞
Science. 2008 Jan 18;319(5861):336-9. doi: 10.1126/science.1150648.
10
Hematopoietic cytokines.造血细胞因子
Blood. 2008 Jan 15;111(2):485-91. doi: 10.1182/blood-2007-03-079681.